#United States #South San Francisco #Slone Partners #David Stern #Mirvie

David Stern Takes the Helm at Mirvie

In a significant move for the field of maternal health, Slone Partners has announced the placement of David Stern as the Chief Executive Officer of Mirvie. This appointment is expected to propel Mirvie, a pioneering pregnancy health company, into new realms of innovation and service for expectant mothers. Having over three decades of experience in women’s health, Stern's leadership comes at a critical time when maternal health is evolving, and the demand for personalized care is greater than ever.

David Stern's previous role as CEO of Kindbody, a network of fertility clinics, and his leadership at Boston IVF give him a wealth of experience crucial for Mirvie’s mission. During his tenure at Symbiomix Therapeutics, he successfully directed the development and commercialization of Solosec, a groundbreaking treatment for bacterial vaginosis. Stern’s impressive track record includes transforming fertility care through strategic growth and product launches, which will serve him well in his new position at Mirvie.

Leslie Loveless, CEO and Managing Partner at Slone Partners, highlighted the importance of this appointment, stating, "Maternal health is at an inflection point, and Mirvie is positioned to lead it. David pairs three decades of women’s health leadership with hands-on experience building commercial businesses, from product launch through a successful acquisition." This indicates a strong belief in Stern’s capabilities to further develop Mirvie's unique offerings.

Mirvie is distinguished by its proprietary Mirvie RNA Platform™, which aims to detect risks related to pregnancy complications at an early stage. This innovative approach allows for tailored healthcare interventions, addressing the significant need for personalization in maternal health. As the co-founder of Mirvie, Dr. Maneesh Jain expressed confidence in his decision to transition the leadership to Stern, remarking on the need for dynamic growth in the face of severe pregnancy complications which affect one in five pregnancies in the U.S.

Stern himself acknowledges the challenges and potential that lie ahead: "Pregnancy is one of the last outdated frontiers of medicine that is still managed largely by one-size-fits-all guidelines. What Maneesh and the team have built is rare molecular insight into the biology of each pregnancy, a clinically validated test, established payer coverage, and growing demand from clinicians and patients." This indicates the transformative potential of Mirvie's technologies in revolutionizing pregnancy care.

Stern’s educational background, including a BA in Biology and Economics from Brandeis University and an MBA from Babson College, complements his professional experience, positioning him as not only a leader in healthcare but also a visionary for the future of maternal health.

The Future of Mirvie

As Mirvie continues to expand its reach and influence in the pregnancy health market, Stern's leadership will be instrumental in harmonizing scientific research with practical applications that benefit women. His vision encompasses the empowerment of both expectant mothers and healthcare professionals through cutting-edge innovations and data-driven insights.

Mirvie’s commitment to ensuring the safety and health of pregnancies relying on the Mirvie RNA Platform™ resonates deeply with many women facing the related uncertainties. The stakes are high, and with leaders like Stern, there’s optimism surrounding the potential to reduce preterm births and enhance maternal health outcomes effectively.

In summary, David Stern's appointment as CEO is not only a significant milestone for Mirvie but also a hopeful sign for the broader landscape of women's health. As challenges continue to grow within maternal healthcare, Mirvie is set to lead the charge with innovative solutions that prioritize both safety and individualized care for expectant mothers. This new chapter promises exciting advancements in maternal healthcare, thanks to Stern's leadership.

About Slone Partners and Mirvie

Slone Partners

With over 25 years of experience, Slone Partners is a leading executive search firm dedicated to the life sciences and healthcare industries. They specialize in finding extraordinary leaders to foster growth and innovation within organizations.

Mirvie

Mirvie is a company focused on addressing pressing clinical issues in women's health, particularly in pregnancy. Their mission encompasses using sophisticated technology to enhance the safety and health of pregnancies, making a meaningful impact on maternal health outcomes.